Healthcare Triangle, Inc. (NASDAQ: HCTI) completed a 1‑for‑60 reverse stock split on February 10, 2026, consolidating 45,417,091 shares into 756,952 shares. The split, effective at 12:01 a.m. Eastern Time, was approved by the board after a special meeting of stockholders on February 2. The new CUSIP for the post‑split shares is 42227W 405, and no fractional shares will be issued; shareholders who would receive a fraction will have their shares rounded up at the participant level.
The reverse split was undertaken to bring the company’s share price above Nasdaq Capital Market’s $1.00 minimum bid‑price requirement and to preserve its listing status. Healthcare Triangle has faced recurring compliance challenges, having received a Nasdaq notice in February 2025 for a 30‑day bid‑price deficiency, a hearing panel decision in July 2025 that required a reverse split by August 8, 2025, and a prior 1‑for‑249 reverse split effective August 1, 2025. As of February 5, 2026, the company’s market capitalization was approximately $2.34 million.
The company’s financial performance underscores the need for the split. In the third quarter of 2025, Healthcare Triangle reported an earnings per share of –$0.42 and a net loss of $1.91 million. Trailing‑twelve‑month earnings through September 30, 2025, were –$6.3 million, and the company’s EBITDA for the same period was –$6.27 million. These losses reflect ongoing investment in technology and market expansion, but have kept the share price below the Nasdaq threshold.
Healthcare Triangle operates in the healthcare information technology sector, offering cloud services, data‑science solutions, and managed services to hospitals, health systems, and life‑science companies. Recent strategic moves include a joint venture in Saudi Arabia and a partnership in the EMEA region, aimed at expanding its global footprint. Despite these initiatives, the company has yet to achieve profitability, and its revenue growth has been modest compared to peers.
The reverse split will not alter the company’s market capitalization or the total value of shareholders’ holdings; it simply consolidates existing shares into fewer, higher‑priced shares. While the action restores Nasdaq compliance, it does not address the underlying financial challenges. Investors will continue to monitor the company’s ability to turn its investments into sustainable earnings and to lift its share price above the regulatory threshold without further structural changes.
The market reacted positively to the announcement, with increased trading activity reflecting relief that the company is taking steps to maintain its Nasdaq listing. However, the long‑term outlook remains uncertain until the company demonstrates a clear path to profitability and a share price that can sustain itself above the $1.00 minimum bid price.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.